{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:10:33Z","timestamp":1775279433267,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3960\/jslrt.25086","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:12:50Z","timestamp":1774908770000},"page":"19-26","source":"Crossref","is-referenced-by-count":0,"title":["Karyotype evolution of multiple myeloma"],"prefix":"10.3960","volume":"66","author":[{"given":"Yosuke","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Ichimura","sequence":"additional","affiliation":[{"name":"Chromosome, Cellular Immunology Analysis Department, SRL, Inc., Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Harukawa","sequence":"additional","affiliation":[{"name":"Chromosome, Cellular Immunology Analysis Department, SRL, Inc., Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozue","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Chromosome, Cellular Immunology Analysis Department, SRL, Inc., Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harunori","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Nonaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Sugitani","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Iwai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoji","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 WHO Classification of Tumours, 5th Edition. Lyon, International Agency for Research on Cancer. 2024."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol. 2005; 23: 6333-6338.","DOI":"10.1200\/JCO.2005.05.021"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Bolli N, Avet-Loiseau H, Wedge DC <i>et al.<\/i> Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014; 5: 2997.","DOI":"10.1038\/ncomms3997"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Rasche L, Chavan SS, Stephens OW <i>et al.<\/i> Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun. 2017; 8: 268.","DOI":"10.1038\/s41467-017-00296-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Rasche L, Schinke C, Maura F <i>et al.<\/i> The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states. Nat Commun. 2022; 13: 4517.","DOI":"10.1038\/s41467-022-32145-y"},{"key":"6","unstructured":"6 Matsumoto Y, Ogawa S, Nonaka K <i>et al.<\/i> Karyotype evolution of a case with diffuse large B-cell lymphoma which caused pathologic splenic rupture. Medical Journal of Japanese Red Cross Kyoto Daiichi Hospital. 2023; 6: 11-24."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Matsumoto Y, Kato D, Muramatsu A <i>et al.<\/i> Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations. Int J Hematol. 2025; 121: 792-800.","DOI":"10.1007\/s12185-025-03938-w"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Rajkumar SV, Dimopoulos MA, Palumbo A <i>et al.<\/i> International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014; 15: e538-e548.","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Venkatesan S, Swanton C. Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome. Am Soc Clin Oncol Educ Book. 2016; 35: e141-e149.","DOI":"10.1200\/EDBK_158930"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Vendramin R, Litchfield K, Swanton C. Cancer evolution: Darwin and beyond. EMBO J. 2021; 40: e108389.","DOI":"10.15252\/embj.2021108389"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Nishio Y, Sakai H, Saiki Y <i>et al.<\/i> Light-chain plasma cell myeloma caused by 14q32\/IGH translocation and loss of the other allele. Int J Hematol. 2019; 109: 572-577.","DOI":"10.1007\/s12185-019-02629-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Sawyer JR, Waldron JA, Jagannath S, Barlogie B. Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet. 1995; 82: 41-49.","DOI":"10.1016\/0165-4608(94)00284-I"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Saxe D, Seo EJ, Bergeron MB, Han JY. Recent advances in cytogenetic characterization of multiple myeloma. Int J Lab Hematol. 2019; 41: 5-14.","DOI":"10.1111\/ijlh.12882"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Maura F, Bolli N, Angelopoulos N <i>et al.<\/i> Genomic landscape and chronological reconstruction of driver events in multiple myeloma. Nat Commun. 2019; 10: 3835.","DOI":"10.1038\/s41467-019-11680-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Alberge JB, Dutta AK, Poletti A <i>et al.<\/i> Genomic landscape of multiple myeloma and its precursor conditions. Nat Genet. 2025; 57: 1493-1503.","DOI":"10.1038\/s41588-025-02196-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Todoerti K, Ronchetti D, Favasuli V <i>et al.<\/i> DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome. Haematologica. 2022; 107: 921-932.","DOI":"10.3324\/haematol.2021.278342"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Ohguchi Y, Ohguchi H. DIS3: The Enigmatic Gene in Multiple Myeloma. Int J Mol Sci. 2023; 24: 4079.","DOI":"10.3390\/ijms24044079"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Herrero AB, Rojas EA, Misiewicz-Krzeminska I, Krzeminski P, Guti\u00e9rrez NC. Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma. Int J Mol Sci. 2016; 17: 2003.","DOI":"10.3390\/ijms17122003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Jovanovi\u0107 KK, Escure G, Demonchy J <i>et al.<\/i> Deregulation and Targeting of TP53 Pathway in Multiple Myeloma. Front Oncol. 2019; 8: 665.","DOI":"10.3389\/fonc.2018.00665"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Van Wier S, Braggio E, Baker A <i>et al.<\/i> Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma. Haematologica. 2013; 98: 1586-1592.","DOI":"10.3324\/haematol.2012.081083"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Saito N, Higashiura K, Ehata K <i>et al.<\/i> Myelodysplastic syndrome of del 20q with plasma cell dysplasia. J Clin Exp Hematop. 2011; 51: 141-145.","DOI":"10.3960\/jslrt.51.141"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 White JS, Zordan A, Batzios C, Campbell LJ. Deletion(20q) as the sole abnormality in plasma cell myeloma is not associated with plasma cells as identified by cIg FISH. Cancer Genet. 2012; 205: 644-652.","DOI":"10.1016\/j.cancergen.2012.10.007"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Mitev L. Evidence of two different molecular mechanisms as a consequence of an isolated 20q- abnormality in a case of multiple myeloma accompanied with myelodysplastic syndrome. Leuk Res Rep. 2021; 16: 100273.","DOI":"10.1016\/j.lrr.2021.100273"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Lee RS, Lohano S, Safdar M. Plasmablastic myeloma with a history of diffuse large B-cell lymphoma. BMJ Case Rep. 2024; 17: e263511.","DOI":"10.1136\/bcr-2024-263511"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Ceparano G, Lorenzini D, Ponzoni M <i>et al.<\/i> Tailored Therapeutic Approach in a Patient With Diffuse Large B-Cell Lymphoma With Meningeal Infiltration, Concurrent Classic Hodgkin Lymphoma, and Smoldering Multiple Myeloma: A Case Report. Cancer Rep (Hoboken). 2025; 8: e70102.","DOI":"10.1002\/cnr2.70102"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Gibbs AC, Batchala PP, Gottlieb CE <i>et al.<\/i> Staging FDG PET\/CT prediction of bone marrow involvement by diffuse large B-cell lymphoma leading to delayed recognition of multiple myeloma. J Hematop. 2025; 18: 49.","DOI":"10.1007\/s12308-025-00667-1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Ganachari P, Dev Vashishta G, Ramani VK, Naik R. A Rare Presentation of Multiple Myeloma as a Second Primary Cancer Sequential to Non-Hodgkin Lymphoma: Case Report. Case Rep Oncol. 2025; 18: 1562-1574.","DOI":"10.1159\/000548795"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/1\/66_25086\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:31:35Z","timestamp":1775277095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/1\/66_25086\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.25086","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25086"}}